http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2166326-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
filingDate 1994-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55f9f8b621f06eeca8a96007d800a14f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_124fdb05dfdf1c07d1f930be3970d5c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bcf6c3f610f7b57951ff1ce3aed4b67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cefa3ca6cf238b203b2e9837bd94d164
publicationDate 1995-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2166326-A1
titleOfInvention Pyridazinone derivatives
abstract Disclosed are a 3(2H)-pyridazinone derivative of the formula (I) or its salt, a process for its production and a pharmaceutical composition containing thereof: (see formula I) (wherein R1, R2 and R3 are each hydrogen C1-4 alkyl, X is chlorine or bromine, Y1 is hydrogen, halogen, nitro, amino or C1-4 alkoxy, Y2 is hydrogen, halogen, hydroxyl, C1-4 alkyl or C1-4 alkoxy, A is C1-5 alkylene which may be substituted by hydroxyl, B is carbonyl or methylene which may be substituted by C1-4 alkyl, and R4 and R5 are each C1-4 alkyl, or R4 is hydrogen and R5 is -Z-Ar (wherein Z is C1-5 alkylene, and Ar is aromatic 6-membered ring which may contain nitrogen), or R4 and R5 together form C2-6 cyclic alkylene, or R4 and R5 form together with the adjacent nitrogen atom 4-substituted piperazine of the formula: (see formula II) wherein R6 is C1-4 alkyl). The derivative and its salt are useful as for a vasodilator, an antiallergic drug and an antiplatelet agent.
priorityDate 1993-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407318370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970

Total number of triples: 41.